Alveo Technologies Inc.

Alameda, CA

UEI: KH96KJCJDNG3
CAGE: 7K4P8
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Active through Jul 24, 2027

Company facts

Self-certified in SAM.gov: For Profit Organization

Manufacturer of Goods
Entity structure: Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov: 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
SAM.gov registration date: Feb 9, 2016
Physical address: 965 Atlantic Ave, Alameda, CA 94501, USA
Website: alveotechnologies.com
Founded: 2015
Employees: 51-250
Estimated annual revenue: $10M-$50M
Industry: Health Care

Pharmaceuticals, Biotechnology & Life Sciences

Pharmaceuticals
SIC code: 28 Chemical & Allied Products
Profiles: LinkedIn

X

Crunchbase

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Jul 28, 2026.

Alveo Technologies Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award	Agency	Obligated	Awarded
R & d services Contract · 75D30124T20347	CDC Pittsburgh	$5,254,375	Sep 30, 2024

Alveo Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is KH96KJCJDNG3.

Alveo Technologies Inc.'s CAGE code is 7K4P8.

Alveo Technologies Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Alveo Technologies Inc.'s physical address in SAM.gov is 965 Atlantic Ave, Alameda, CA 94501, USA.

Yes. Alveo Technologies Inc.'s SAM.gov registration is active through July 24, 2027.

Alveo Technologies Inc.'s most recent federal contract award is R & d services (75D30124T20347), from CDC Pittsburgh, on September 30, 2024.

On GovTribe

Try for free Login